Janus Henderson Investors US’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$34M Sell
472,214
-255,300
-35% -$17.6M 0.03% 517
2016
Q4
$45.1M Buy
727,514
+362,886
+100% +$22.2M 0.04% 458
2016
Q3
$23.6M Buy
364,628
+127,500
+54% +$8.49M 0.02% 561
2016
Q2
$15M Buy
237,128
+39,800
+20% +$2.35M 0.01% 614
2016
Q1
$11.4M Sell
197,328
-211,400
-52% -$12M 0.01% 648
2015
Q4
$21.9M Sell
408,728
-85,600
-17% -$4.83M 0.02% 590
2015
Q3
$25.2M Buy
494,328
+345,234
+232% +$18.6M 0.02% 557
2015
Q2
$8.4M Buy
149,094
+118,466
+387% +$7.48M 0.01% 723
2015
Q1
$2.2M Sell
30,628
-124,244
-80% -$8.07M ﹤0.01% 895
2014
Q4
$8.68M Buy
154,872
+117,772
+317% +$6.15M 0.01% 718
2014
Q3
$1.83M Sell
37,100
-25,300
-41% -$1.29M ﹤0.01% 908
2014
Q2
$3.16M Sell
62,400
-250,501
-80% -$12.4M ﹤0.01% 844
2014
Q1
$14M Sell
312,901
-68,200
-18% -$3.06M 0.01% 607
2013
Q4
$17.9M Sell
381,101
-321,241
-46% -$16.3M 0.02% 558
2013
Q3
$37.1M Sell
702,342
-441,858
-39% -$21.4M 0.04% 417
2013
Q2
$51.6M Buy
+1,144,200
New +$54.3M 0.05% 356

Other funds holding RMD

Janus Henderson Investors US's RMD Position: Q1 2017 in Review

Janus Henderson Investors US reduced its ResMed (RMD) stake by 35% in Q1 2017, selling an estimated $17.6M and leaving 472,214 shares worth $34M. The position accounts for 0.03% of the portfolio, ranked #517.

Janus Henderson Investors US first reported a position in RMD in Q2 2013 and has held it in 16 quarters since. The position peaked at $51.6M in Q2 2013. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2017.

  • Janus Henderson Investors US held 472,214 shares of ResMed worth $34M as of Q1 2017.
  • Janus Henderson Investors US sold 255,300 ResMed shares in Q1 2017, an estimated $17.6M.
  • ResMed made up 0.03% of Janus Henderson Investors US's portfolio in Q1 2017, its #517 holding.
  • Janus Henderson Investors US first reported a position in ResMed in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's ResMed position peaked at $51.6M in Q2 2013.
  • 374 funds tracked by Wall St. Rank held ResMed as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.